日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy

利用易发生抗体依赖性细胞毒性(ADCC)的纳米抗体构建体清除肿瘤浸润的IL1R2+调节性T细胞,可提高抗PD-1免疫疗法的疗效。

Sana M Arnouk,Daliya Kancheva ,Helena Van Damme,Guillaume E Courtoy,Romina Mora Barthelmess,Jolien Van Craenenbroeck,Els Lebegge,Yvon Elkrim,Naela Assaf,Yves Heremans,Aleksandar Murgaski,Timo W M De Groof,Emile Clappaert ,Ayla Debraekeleer,Jan Brughmans,Gillian Blancke ,Máté Kiss ,Ramses Forsyth,Wim Waelput,Louis Boon,Nick Devoogdt,Catelijne Stortelers,Nadja van Boxel,Bruno Dombrecht,Lars Vereecke ,Cécile Vincke,Geert Raes,Damya Laoui,Jo A Van Ginderachter

Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy

利用易发生抗体依赖性细胞毒性(ADCC)的纳米抗体构建体清除肿瘤浸润的IL1R2+调节性T细胞,可提高抗PD-1免疫疗法的疗效。

Sana M Arnouk ,Daliya Kancheva ,Helena Van Damme ,Guillaume E Courtoy ,Romina Mora Barthelmess ,Jolien Van Craenenbroeck ,Els Lebegge ,Yvon Elkrim ,Naela Assaf ,Yves Heremans ,Aleksandar Murgaski ,Timo W M De Groof ,Emile Clappaert ,Ayla Debraekeleer ,Jan Brughmans ,Gillian Blancke ,Máté Kiss ,Ramses Forsyth ,Wim Waelput ,Louis Boon ,Nick Devoogdt ,Catelijne Stortelers ,Nadja van Boxel ,Bruno Dombrecht ,Lars Vereecke ,Cécile Vincke ,Geert Raes ,Damya Laoui ,Jo A Van Ginderachter

Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers

优化抗体PET成像:纳米抗体和迷你抗体样PET示踪剂的临床前比较分析

Katty Zeven ,Herlinde Dierick ,Matthijs Sevenois ,Henri Baudhuin ,Laurent Navarro ,Sonja Van den Block ,Jelena Saliën ,Karine Breckpot ,Jessica Bridoux ,Timo W M De Groof # ,Nick Devoogdt #

Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors

针对HER2阳性实体瘤的纳米抗体CAR-T细胞的临床前开发和筛选

Meeus, Fien; Van der Vreken, Arne; Autaers, Dorien; De Groof, Timo W M; Esprit, Arthur; Franceschini, Lorenzo; Parone, Philippe; Goyvaerts, Cleo; De Vlaeminck, Yannick; Devoogdt, Nick; Breckpot, Karine

Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion

基于纳米抗体的Pannexin1通道抑制剂可提高心肌缺血/再灌注后的存活率。

Rusiecka, Olga M; Molica, Filippo; Clochard, Linda; Van Campenhout, Raf; De Groof, Timo W M; Bes, Viviane; Devoogdt, Nick; Muyldermans, Serge; Vinken, Mathieu; Kwak, Brenda R

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

AXL 特异性单域抗体在急性髓系白血病中表现出诊断潜力和抗肿瘤活性

Niels Vandewalle, Hatice Satilmis, Emma Verheye, Rong Fan, Yanmeng Wang, Timo W M De Groof, Jessica Bridoux, Tessa Kerre, Nathan De Beule, Ann De Becker, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Karine Breckpot, Nick Devoogdt, Kim De Veirman

Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β

利用针对人CD8β的纳米抗体放射性示踪剂对CD8+T细胞动态进行特异性成像

De Groof, Timo W M; Lauwers, Yoline; De Pauw, Tessa; Saxena, Mohit; Vincke, Cécile; Van Craenenbroeck, Jolien; Chapon, Catherine; Le Grand, Roger; Raes, Geert; Naninck, Thibaut; Van Ginderachter, Jo A; Devoogdt, Nick

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

仔细检查胞外域对嵌合抗原受体的激活:针对多发性骨髓瘤细胞的单域抗体的经验凸显了逐案优化的必要性

Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, Quentin Lecocq, Janik Puttemans, Pieterjan Debie, Timo W M De Groof, Cleo Goyvaerts, Kim De Veirman #, Karine Breckpot #, Nick Devoogdt #

Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy

利用放射性标记纳米抗体示踪剂进行核成像的进展可支持癌症免疫治疗

Zeven, Katty; Lauwers, Yoline; De Mey, Lynn; Debacker, Jens M; De Pauw, Tessa; De Groof, Timo W M; Devoogdt, Nick

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury

基于纳米抗体的 pannexin1 通道抑制剂可减轻急性肝损伤中的炎症

Raf Van Campenhout #, Timo W M De Groof #, Prashant Kadam, Brenda R Kwak, Serge Muyldermans, Nick Devoogdt #, Mathieu Vinken #